Management tracks: Axovant, Revance

By BC Staff | May 29, 2018 | 10:36 PM GMT

Axovant Sciences Ltd. (NASDAQ:AXON) hired Gavin Corcoran as EVP of R&D and appointed Michael Hayden as senior scientific advisor and chairman of the neurology